|
SCAMP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.190000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.130400E-02 |
| Normal-vs-Stage2 |
8.701600E-03 |
| Normal-vs-Stage3 |
8.146100E-02 |
| Normal-vs-Stage4 |
2.180600E-01 |
| Stage1-vs-Stage2 |
8.413800E-02 |
| Stage1-vs-Stage3 |
7.340200E-01 |
| Stage1-vs-Stage4 |
9.510600E-01 |
| Stage2-vs-Stage3 |
1.919980E-01 |
| Stage2-vs-Stage4 |
1.538000E-01 |
| Stage3-vs-Stage4 |
7.725400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.198200E-01 |
| Normal-vs-AfricanAmerican |
4.896200E-02 |
| Normal-vs-Asian |
1.308040E-01 |
| Caucasian-vs-AfricanAmerican |
1.548020E-01 |
| Caucasian-vs-Asian |
4.787200E-01 |
| AfricanAmerican-vs-Asian |
6.273600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.604500E-02 |
| Normal-vs-Female |
3.746000E-02 |
| Male-vs-Female |
9.792000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.393430E-01 |
| Normal-vs-Age(41-60Yrs) |
6.717600E-02 |
| Normal-vs-Age(61-80Yrs) |
8.616400E-03 |
| Normal-vs-Age(81-100Yrs) |
3.542200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.070400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.028180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.046200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.762780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.783200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.185000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.062400E-01 |
| Classical-VS-Follicular |
1.78920999999166E-05 |
| Classical-VS-Other |
1.861630E-01 |
| Classical-VS-Normal |
4.162600E-01 |
| Tall-VS-Follicular |
7.135400E-03 |
| Tall-VS-Other |
2.357200E-01 |
| Tall-VS-Normal |
7.372200E-01 |
| Follicular-VS-Other |
7.193000E-01 |
| Follicular-VS-Normal |
3.62529999999861E-05 |
| Other-VS-Normal |
7.713800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.373600E-02 |
| Normal-vs-N1 |
3.037200E-03 |
| N0-vs-N1 |
1.682630E-01 |
|
|
